AN2 Therapeutics, Inc. (ANTX) has 11 SEC Form 4 insider filings on record in the last 90 days. That includes 1 insider purchase totalling $12K, and 5 sales totalling $343K. Most recent filing: Sept. 16, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 16, 2026 filed Sept. 15, 2026 | Trenor Cameron C. III Chief Medical Officer | $0 | 350,000 | +100% | No | |
|
|
||||||
| Sept. 11, 2026 filed Sept. 9, 2026 | Readnour Robin Shane Director | −$6,675 | 1,108 | −0% | Yes | |
|
|
||||||
| Sept. 8, 2026 filed Sept. 3, 2026 | Readnour Robin Shane Director | −$97,323 | 16,119 | −3% | Yes | |
|
|
||||||
| Sept. 4, 2026 filed Sept. 1, 2026 | Williams Sarah Joanne Principal Accounting Officer | −$1,504 | 272 | −0% | No | |
|
|
||||||
| Sept. 2, 2026 filed Sept. 1, 2026 | FitzPatrick Margaret M Director | +$11,602 | 2,098 | +24% | No | |
|
|
||||||
Showing the 5 most recent of 11 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free